Literature DB >> 21262950

Drug formulations that require less than 0.1 mL of stock solution to prepare doses for infants and children.

Navjeet Uppal, Baseer Yasseen, Winnie Seto, Christopher S Parshuram.   

Abstract

Intravenous doses of medications require formulations that permit accurate preparation and administration. Current equipment does not permit accurate measurement of volumes less than 0.1 mL. In a study of four hypothetical standard pediatric patients, we found that 28 common medications required less than 0.1 mL of available formulation to prepare the dose. In a clinical study of actual use in a pediatric intensive care unit (ICU), 5245 (7.4%) of 71 218 intravenous doses required preparation from less than 0.1 mL of stock solution. For 28.5% of the 1531 ICU admissions, at least one dose was prepared from a volume of less than 0.1 mL. Our findings identify a substantial source of dosing error. Correction will require revision of preparation methods, regulatory requirements and manufacturing practices.

Entities:  

Mesh:

Year:  2011        PMID: 21262950      PMCID: PMC3050974          DOI: 10.1503/cmaj.100467

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  15 in total

1.  Accidental iatrogenic intoxications by cytotoxic drugs: error analysis and practical preventive strategies.

Authors:  B Zernikow; E Michel; G Fleischhack; U Bode
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

Review 2.  Common errors of drug administration in infants: causes and avoidance.

Authors:  B J Anderson; J F Ellis
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

3.  Occurrence and impact of unanticipated variation in intravenous methotrexate dosing.

Authors:  Christopher S Parshuram; L Lee Dupuis; Teresa To; Sheila S Weitzman; Gideon Koren; Andreas Laupacis
Journal:  Ann Pharmacother       Date:  2006-04-25       Impact factor: 3.154

Review 4.  Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.

Authors:  Laura Cuzzolin; Alessandra Atzei; Vassilios Fanos
Journal:  Expert Opin Drug Saf       Date:  2006-09       Impact factor: 4.250

5.  Systematic evaluation of errors occurring during the preparation of intravenous medication.

Authors:  Christopher S Parshuram; Teresa To; Winnie Seto; Angela Trope; Gideon Koren; Andreas Laupacis
Journal:  CMAJ       Date:  2008-01-01       Impact factor: 8.262

6.  Medication errors and adverse drug events in pediatric inpatients.

Authors:  R Kaushal; D W Bates; C Landrigan; K J McKenna; M D Clapp; F Federico; D A Goldmann
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

7.  Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example.

Authors:  R E Ferner; N J Langford; C Anton; A Hutchings; D N Bateman; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

8.  Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities.

Authors:  Navjeet K Uppal; Lee L Dupuis; Christopher S Parshuram
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

9.  Effect of computer order entry on prevention of serious medication errors in hospitalized children.

Authors:  Kathleen E Walsh; Christopher P Landrigan; William G Adams; Robert J Vinci; John B Chessare; Maureen R Cooper; Pamela M Hebert; Elisabeth G Schainker; Thomas J McLaughlin; Howard Bauchner
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

10.  Pharmacotherapy in pediatric critical illness: a prospective observational study.

Authors:  Conor McDonnell; Stanley Hum; Helena Frndova; Christopher S Parshuram
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

View more
  7 in total

Review 1.  Challenges Associated with Route of Administration in Neonatal Drug Delivery.

Authors:  Matthew W Linakis; Jessica K Roberts; Anita C Lala; Michael G Spigarelli; Natalie J Medlicott; David M Reith; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

2.  Discontinuation of paediatric injectable digoxin: A loss for optimal drug therapy in children.

Authors:  Pascal Bédard; Isabelle Goyer
Journal:  Paediatr Child Health       Date:  2016-04       Impact factor: 2.253

Review 3.  Neonatal drug therapy: The first frontier of therapeutics for children.

Authors:  K Allegaert; J van den Anker
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

4.  Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine.

Authors:  Merja Kokki; Marja Heikkinen; Pyry Välitalo; Heidi Hautajärvi; Juho Hokkanen; Hanna Pitkänen; Ulla Sankilampi; Veli-Pekka Ranta; Hannu Kokki
Journal:  Br J Clin Pharmacol       Date:  2016-12-05       Impact factor: 4.335

Review 5.  Accuracy of intravenous and enteral preparations involving small volumes for paediatric use: a review.

Authors:  L P Ainscough; J L Ford; C W Morecroft; M Peak; M A Turner; A J Nunn; M Roberts
Journal:  Eur J Hosp Pharm       Date:  2017-01-04

6.  Development of Guidelines for Accurate Measurement of Small Volume Parenteral Products Using Syringes.

Authors:  Melanie A Jordan; Dimpa Choksi; Kelsey Lombard; Lynn R Patton
Journal:  Hosp Pharm       Date:  2019-09-06

7.  Medicine preparation errors in ten Spanish neonatal intensive care units.

Authors:  Ainara Campino; Casilda Arranz; Maria Unceta; Miguel Rueda; Beatriz Sordo; Pilar Pascual; Ion Lopez-de-Heredia; Elena Santesteban
Journal:  Eur J Pediatr       Date:  2015-08-27       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.